Search
Search
#1. Treatment Options for Carbapenem-Resistant Gram-Negative ...
由 M Fritzenwanker 著作 · 2018 · 被引用 80 次 — Depending on the site and severity of the infection, preparations such as trimethoprim/sulfamethoxazole, nitrofurantoin, fosfomycin, aminoglycosides, and ...
#2. Combination Regimens for Treatment of Carbapenem ...
Here, we assessed outcomes in patients with BSIs caused by phenotypically carbapenem-resistant K. pneumoniae (CRKP) according to the number of ...
#3. Tigecycline therapy for carbapenem-resistant Klebsiella ...
CRKP are generally resistant to multiple antibiotic classes. As a result, treatment options for CRKP include polymyxins, tigecycline, aminoglycosides and ...
#4. Infections Caused by Carbapenem-Resistant ... - Frontiers
Currently, antibiotic options for the treatment of carbapenem-resistant Enterobacteriaceae (CRE) are very limited, with polymyxins, ...
#5. Treatment Options for Carbapenem-resistant Gram-negative ...
Acquired carbapenem resistance among the more commonly encountered species in the family Enterobacteriaceae, such as Klebsiella pneumoniae and ...
#6. Treatment of carbapenem-resistant Klebsiella pneumoniae
The impact of combination therapy on Klebsiella pneumo- niae infection has rarely been evaluated. In an old study of. 230 patients with K. pneumoniae bacteremia ...
#7. Successful control of the first carbapenem-resistant Klebsiella ...
Klebsiella pneumoniae is one of the leading causes of hospital-acquired infections globally. Carbapenems are widely used for the treatment of ...
#8. Prevalence of carbapenem-resistant Klebsiella pneumoniae inf
Prevalence of Carbapenem-Resistant Klebsiella pneumoniae Infection in a Northern Province in China: Clinical Characteristics, Drug Resistance, ...
#9. What are the treatment options for resistant Klebsiella ...
由 M Spaziante 著作 · 2020 · 被引用 5 次 — baumannii) whereas for carbapenem resistant K. pneumoniae the all-cause mortality at day 49 was similar between cefiderocol and BAT groups (23.5 ...
#10. Review of therapeutic options for infections with carbapenem ...
In a study by Michalopoulos et al. ICU patients suffering from carbapenem-resistant K. pneumoniae infections were treated with fosfomycin ( ...
#11. Rapid Spread of Carbapenem-Resistant Klebsiella ...
Patients with carbapenem-resistant K pneumoniae infection or colonization were identified by review of microbiology records at 2 hospitals ...
#12. Emergence of Carbapenem-Resistant Klebsiella pneumoniae
pneumoniae strains resistant to this class of antibiotics (CRKP), causing a problem in the clinical treatment of patients. This investigation reports the ...
#13. Emergence of carbapenem-resistant hypervirulent Klebsiella ...
The emergence of a hypervirulent plasmid in prevalent strains of Klebsiella pneumoniae threatens the effective prevention and treatment of ...
#14. Klebsiella pneumoniae in Healthcare Settings | HAI | CDC
Some Klebsiella bacteria have become highly resistant to ... carbapenems will not work to kill the bacteria and treat the ...
#15. Treatment Options for Colistin Resistant Klebsiella pneumoniae
Since colistin is one of the few treatment options for carbapenem-resistant K. pneumoniae infections, colistin resistance represents a challenge due to the ...
#16. Risk Factors for Carbapenem-Resistant Klebsiella ...
Aims: Carbapenem-resistant Klebsiella pneumoniae (CRKP) infection has been rapidly emerging as a life-threatening nosocomial disease in many ...
#17. Klebsiella pneumoniae, Carbapenem-resistant (CRKP)
Klebsiella infections that are not drug-resistant can be treated with antibiotics. Infections caused by KPC-producing bacteria can be difficult to treat because ...
#18. IDSA Guidance on the Treatment of Antimicrobial-Resistant ...
The most common carbapenemases in the United States are K. pneumoniae carbapenemases (KPCs), ...
#19. In-vivo loss of carbapenem resistance by extensively drug ...
MDR K. pneumoniae isolates consist of those resistant to ... These infections required iterative treatment with carbapenems.
#20. Attributable Mortality Rate for Carbapenem-Resistant ...
pneumoniae. Of these 319 patients, 39 (12.2%) developed a bloodstream infection, for an overall rate of 0.59 episodes of carbapenem-resistant K. pneumoniae ...
#21. a multi-centre study on clinical outcome and therapeutic options
Infections due to carbapenem-resistant Klebsiella pneumoniae (CR-KP) have emerged as ... Colistin remains a valuable antimicrobial agent for treating these ...
#22. Clinical characteristics and expression levels of efflux pump ...
Objectives Tigecycline is a treatment option for infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP).
#23. Treatment of carbapenem-resistant Klebsiella pneumoniae
PDF | The increasing incidence of carbapenem-resistant Klebsiella pneumoniae (CR-KP) fundamentally alters the management of patients at risk to be.
#24. Carbapenem-resistant Klebsiella pneumoniae infection
Video abstract of an original research "Prevalence of carbapenem-resistant Klebsiella pneumoniae infection in a northern province in ...
#25. Treatment Options to Address the Threat of Carbapenem ...
Antimicrobial agents currently used for treatment of infections caused by carbapenem-resistant Enterobacteriaceae (CRE) include carbapenem ...
#26. Risk factors and outcomes of carbapenem-resistant Klebsiella ...
pneumoniae infections is probably due to the delete in the beginning of an appropriate antibiotic treatment, rather than to the increased ...
#27. Clinical features, diagnosis, and treatment of Klebsiella ...
Of the pathogenic Klebsiella species, K. pneumoniae is the most prevalent and clinically important. Infections with K. pneumoniae are usually ...
#28. Carbapenem-Resistant Klebsiella Pneumoniae Osteomyelitis ...
These microbes produce enzymes that degrade carbapenems, a treatment of last resort for other infections. CR-KP infections are commonly treated with tigecycline ...
#29. Synergistic activity of fosfomycin–meropenem and fosfomycin ...
Carbapenem -resistant Klebsiella pneumoniae (CR-Kp) infections are difficult to treat and are associated with a high mortality rate.
#30. Therapeutic strategy for pandrug-resistant Klebsiella ...
The double carbapenem regimen has been proposed as a therapeutic option. •. A PDR K. pneumoniae bloodstream infection was treated successfully ...
#31. Risk factors for infection with carbapenem-resistant Klebsiella ...
Objective: To evaluate the association between quinolone exposure and the emergence of carbapenem-resistant Klebsiella pneumoniae (CRKP) and to ...
#32. Disease burden and molecular epidemiology of carbapenem ...
Disease burden and molecular epidemiology of carbapenem-resistant Klebsiella pneumonia infection in a tertiary hospital in China.
#33. Comparison of Bloodstream Infections With Carbapenem ...
All adult (≥18 years) patients who have monobacterial BSI with CRKp or carbapenem hetero-resistant Klebsiella pneumoniae and treated by ...
#34. Klebsiella-pneumoniae-resistance-Germany-risk-assessment ...
Phase III clinical trials of cefiderocol for the treatment of carbapenem-resistant gram-negative infections (EudraCT: 2015-004703-23; ...
#35. Anatomy of an extensively drug-resistant Klebsiella ... - PNAS
Carbapenem -resistant Klebsiella pneumoniae belongs to the “critical-priority” tier ... hypervirulent K. pneumoniae in a subcutaneous model of infection with ...
#36. Host immunology and rational immunotherapy for ... - JCI Insight
Infections due to carbapenem-resistant Klebsiella pneumoniae have emerged as ... Il2rg-dependent cells are required for host resistance to ST258 Infection.
#37. Critical Review of Double-Carbapenem Therapy for the ...
Clinical Studies Evaluating Double-Carbapenem Therapy (DCT) for the Treatment of Carbapenemase-Producing Klebsiella pneumoniae.
#38. Colistin resistance superimposed to endemic carbapenem ...
carbapenem -resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, ... resistance against colistin, a key drug for treatment.
#39. risk factors for progression to infection Carbapenem-resistant ...
Types of systemic carbapenem-resistant Klebsiella pneumoniae infections included bacteremia (n = 15, 62.5%), ventilator-associated pneumonia (n = 4, 16.6%), ...
#40. Management of carbapenem-resistant Enterobacteriaceae ...
High rate of colistin resistance among patients with carbapenem- · resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin Microbiol ...
#41. Evaluation and Identification of Carbapenem Resistant ...
Background and Objectives: Klebsiella pneumonia is a facultative anaerobe bacterium from enterobacteriaceae family, which causes a wide range of diseases, ...
#42. Double carbapenem regimen used as salvage therapy to treat ...
Carbapenemase-producing Klebsiella pneumoniae is an emerging threat ... to multidrug-resistant Klebsiella pneumoniae treated successfully.
#43. Emerging carbapenem-resistant Klebsiella pneumoniae ...
AICU, adult intensive care unit; AMR, antimicrobial resistance; BAL, bronchoalveolar lavage; BSI, bloodstream-associated infection; ENA, ...
#44. Minocycline in the Treatment of Carbapenem-Resistant <em ...
We present our experience using high dose MIN for treatment of carbapenem resistant Klebsiella pneumoniae infections during the period of national shortage of ...
#45. Role of Carbapenem Combination Therapy - Clinical ...
Treatment Outcome of Bacteremia Due to Non–Carbapenemase-producing Carbapenem-Resistant Klebsiella pneumoniae Bacteremia: Role of Carbapenem ...
#46. The effect of double-carbapenem therapy on mortality rates ...
Abstract. Introduction: Infection with the bacteria carpamenease-producing Klebsiella pneumoniae represents a significant cause of mortality in ...
#47. Treatment of carbapenem-resistant Klebsiella pneumoniae: the state ...
The increasing incidence of carbapenem-resistant Klebsiella pneumoniae (CR-KP) fundamentally alters the management of patients at risk to be colonized or ...
#48. SUCCESSFUL TREATMENT OF CARBAPENEM RESISTANT ...
Corpus ID: 212525351. SUCCESSFUL TREATMENT OF CARBAPENEM RESISTANT KLEBSIELLA PNEUMONIAE WITH COMBINATION OF MEROPENEM & COLISTIN-A CASE REPORT.
#49. Klebsiella pneumoniae and Healthcare Acquired Infections
Next, applying strict contact precautions can further prevent the spread of infection. Most cases of carbapenem resistant pneumonia caused by ...
#50. Klebsiella pneumoniae treatment
Some Klebsiella bacteria have become highly resistant to antibiotics. When bacteria such as Klebsiella pneumoniae produce an enzyme known as a carbapenemase ...
#51. What is the best treatment for klebsiella pneumoniae?
pneumoniae are resistant to most antibiotics, including carbapenems, which are considered last-resort drugs. How do you get Klebsiella ...
#52. Plazomicin - Wikipedia
Plazomicin, sold under the brand name Zemdri, is an aminoglycoside antibiotic used to treat ... It also demonstrates potent in vitro activity versus carbapenem-resistant ...
#53. Implementing Rapid Diagnostic Tests to Augment ...
A recent study found delays in antimicrobial therapy in patients with carbapenem-resistant and -susceptible Enterobacteriaceae infections are ...
#54. UpToDate – Evidence-based Clinical Decision Support
With more than 25 medical specialties, UpToDate enables confidence and provides clarity in decision-making as you treat each patient—even when evidence ...
#55. How is klebsiella pneumoniae treated? - Movie Cultists
Klebsiella infections that are not drug-resistant can be treated with antibiotics. Infections caused by KPC-producing bacteria can be difficult to treat because ...
#56. 2019 NARMS Update: Integrated Report Summary | FDA
The majority (78%) of Salmonella from humans were not resistant to any of the ... Additional isolates surveyed were: Klebsiella pneumoniae, ...
#57. DSHS Authors: 2021 Research Articles by DSHS Staff - Texas ...
Nutt A, et al. Regional outbreak of multidrug-resistant Klebsiella pneumoniae carbapenemase-producing Pseudomonas Aeruginosa. Infect Control ...
#58. Frequently Asked Questions | COVID-19
Getting COVID-19 (or any infection) more than once is called ... Sometimes infected people don't have symptoms (sometimes referred to as ...
#59. Transplant Infections: Fourth Edition - 第 380 頁 - Google 圖書結果
Deconstructing the infection control bundles for the containment of carbapenem-resistant Enterobacteriaceae. Curr Opin Infect Dis. 2013;26(4): 378–87.
#60. Enterobacteriaceae Antimicrobial Agents and Resistance: ...
Colistin resistant Klebsiella pneumoniae: report of a cluster of 24 cases from a ... Treating complicated carbapenem-resistant enterobacteriaceae infections ...
#61. Antibiotic Resistance: Challenges and Opportunities, An ...
Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of ... The effects of group 1 versus group 2 carbapenems on imipenem-resistant ...
#62. Bacterial infections PQRS Flashcards | Quizlet
S.pneumoniae, legionella, H. influenzae, K. pneumoniae, S. aureus. VAP pathogens ... first-line treatment for acute uncomplicated pyelonephritis.
#63. Sample letters for Incentive Plans, Reward or Bonus. - Amon + ...
PURTABS are a part of the EvaClean Infection Control System for up to 3X the ... Acinetobacter baumannii, Carbapenem-resistant Klebsiella pneumoniae, ...
#64. bla drug. The FDA has given approval to a prescription ...
The FDA has given approval to a prescription medication used to treat ... antimicrobials particularly in carbapenem resistant Enterobacteriaceae (CRE) is an ...
carbapenem-resistant klebsiella pneumoniae treatment 在 Carbapenem-resistant Klebsiella pneumoniae infection 的八卦
Video abstract of an original research "Prevalence of carbapenem-resistant Klebsiella pneumoniae infection in a northern province in ... ... <看更多>